Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Investor Relations

AMGN Articles Amgen Inc.

home / stock / amgn / amgn articles

AMGN AMGN Quote AMGN Short AMGN News AMGN Articles AMGN Message Board

Articles | Amgen Inc. (NASDAQ:AMGN)

  • Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments | Benzinga

    Gilead Sciences, Inc. (NASDAQ:GILD) witnessed a flurry of Wall Street speculation regarding its potential involvement in the obesity drug market. B...

    • June 21, 2024 03:42:22 pm
    • |
    • Benzinga
    • |
      • AMGN Stock
      • AMGN Quote
      • AMGN Short
      • AMGN News
      • AMGN Articles
      • AMGN Message Board
  • Here's How Much You Would Have Made Owning Amgen Stock In The Last 20 Years | Benzinga

    Amgen (NASDAQ:AMGN) has outperformed the market over the past 20 years by 1.01% on an annualized basis producing an average annual return of 8.86%....

    • May 31, 2024 06:00:45 pm
    • |
    • Benzinga
    • |
      • AMGN Stock
      • AMGN Quote
      • AMGN Short
      • AMGN News
      • AMGN Articles
      • AMGN Message Board
  • Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug | Benzinga

    Tuesday, the FDA approved Amgen Inc (NASDAQ:AMGN) Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to AstraZeneca Plc’s (NASDA...

    • May 29, 2024 04:51:29 pm
    • |
    • Benzinga
    • |
      • AMGN Stock
      • AMGN Quote
      • AMGN Short
      • AMGN News
      • AMGN Articles
      • AMGN Message Board
  • If You Invested $1000 In This Stock 20 Years Ago, You Would Have $5,700 Today | Benzinga

    Amgen (NASDAQ:AMGN) has outperformed the market over the past 20 years by 1.07% on an annualized basis producing an average annual return of 9.12%....

    • May 21, 2024 03:00:42 pm
    • |
    • Benzinga
    • |
      • AMGN Stock
      • AMGN Quote
      • AMGN Short
      • AMGN News
      • AMGN Articles
      • AMGN Message Board
  • Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient Population | Benzinga

    Sunday, Amgen Inc (NASDAQ:AMGN) and AstraZeneca Plc (NASDAQ:AZN) announced the results of the Phase 2a COURSE trial o...

    • May 20, 2024 06:38:41 pm
    • |
    • Benzinga
    • |
      • AMGN Stock
      • AMGN Quote
      • AMGN Short
      • AMGN News
      • AMGN Articles
      • AMGN Message Board
  • Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch | Benzinga

    President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA)...

    • May 18, 2024 02:19:14 pm
    • |
    • Benzinga
    • |
      • AMGN Stock
      • AMGN Quote
      • AMGN Short
      • AMGN News
      • AMGN Articles
      • AMGN Message Board
  • 4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly | Benzinga

    The obesity market has garnered much interest lately, ever since Novo Nordisk (NYSE: NVO) received FDA approval for its obesity drug Wegovy in 2021...

    • May 17, 2024 07:24:25 pm
    • |
    • Benzinga
    • |
      • AMGN Stock
      • AMGN Quote
      • AMGN Short
      • AMGN News
      • AMGN Articles
      • AMGN Message Board
  • FDA Gives Accelerated Approval To Amgen's Drug For Small Cell Lung Cancer Patients | Benzinga

    Thursday, the FDA approved Amgen Inc’s (NASDAQ:AMGN) Imdelltra (tarlatamab-dlle) for the treatment of adult patients with exte...

    • May 17, 2024 02:01:55 pm
    • |
    • Benzinga
    • |
      • AMGN Stock
      • AMGN Quote
      • AMGN Short
      • AMGN News
      • AMGN Articles
      • AMGN Message Board
  • Should You Hold Viking Therapeutics in Your Portfolio? | Benzinga

    Viking Therapeutics (NASDAQ: VKTX), a clinical-stage company focused on developing novel therapeutics for metabolic and endocrine disorders, has be...

    • May 15, 2024 07:43:24 pm
    • |
    • Benzinga
    • |
      • AMGN Stock
      • AMGN Quote
      • AMGN Short
      • AMGN News
      • AMGN Articles
      • AMGN Message Board
Next 10
Stock Information
Get AMGN Alerts

News, Short Squeeze, Breakout and More Instantly...

Amgen Inc. Company Name:

AMGN Stock Symbol:

NASDAQ Market:

Amgen Inc. Website:

Amgen Inc. Logo

Ad

Investor Relations
RECENT AMGN NEWS
  • AMGN - These Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Over

    2024-12-12 14:23:18 ET It's been a banner year for the stock market. However, not every stock has been a winner as some sectors performed better than others. Tech and utilities soared, while others like real estate and healthcare underperformed. So what are the five worst performers on ...

  • AMGN - AMGEN ANNOUNCES 2025 FIRST QUARTER DIVIDEND

    AMGEN ANNOUNCES 2025 FIRST QUARTER DIVIDEND PR Newswire THOUSAND OAKS, Calif. , Dec. 10, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the first quarter of 2025. The dividend will ...

  • AMGN - 3 Biotech Stocks Revolutionizing Cancer Treatment

    2024-12-10 09:38:59 ET Biotech companies are making monumental strides in cancer treatment, leveraging cutting-edge technologies to redefine the field. Given the robust prospect, investors looking for fundamentally sound biotech stocks might consider adding Regeneron Pharmaceuticals (REGN...

  •
  • Research
  • Stock Search
  • News Releases
  • Articles
  • Topics
  • Message Boards
  • Trending Stocks
  • Trending Feed
  • Trending Alerts
  • Watchlist
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your Twitter Account

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

Trending Stock Alerts

Trending Stock Alerts

Our Next Stock Alert could be Coming in Minutes!

Sign Up Today To Get Full Access To Our Next Stock Report!

  • Day Before Email and Text Notifications of New Alerts
  • Day of Email and Text Notifications
  • Trending Stocks, Watchlist and News Releases
  • Mobile App Notifications
Trending Stock Alerts

Get AMGN Alerts

Get AMGN Alerts

News, Short Squeeze, Breakout and More Instantly...

Sign up or login to continue

Sign up or login to continue.

Forgot password?


Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.

Disclaimer

This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a any stock financial position. any stock's financial position and all other information regarding the featured Company should be verified directly with any stock. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in any company is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of any stock's shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Please read our full disclaimer for compensation and more detailed information.

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

| X

| Facebook

| BlueSky

| LinkedIn

| Telegram

| Discord

Contact

Privacy

Terms of Service

Disclaimer

© 2024 Market Wire News 1